Walmsley, S., Smith, D. E., Górgolas Hernández-Mora, M., Cahn, P. E., Lutz, T., Lacombe, K., . . . Ait-Khaled, M. (2024). Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: Week 48 pooled results from the TANGO and SALSA studies.
Citación estilo ChicagoWalmsley, Sharon, et al. Efficacy and Safety of Switching to Dolutegravir/lamivudine in Virologically Suppressed People With HIV-1 Aged ≥ 50 Years: Week 48 Pooled Results From the TANGO and SALSA Studies. 2024.
Cita MLAWalmsley, Sharon, et al. Efficacy and Safety of Switching to Dolutegravir/lamivudine in Virologically Suppressed People With HIV-1 Aged ≥ 50 Years: Week 48 Pooled Results From the TANGO and SALSA Studies. 2024.